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To the Editor
Visoiu and Verdecchia
1 reported the case of a woman 
suffering from chronic chest wall pain following a 
massive pulmonary embolus treated with intercostal 
nerve blocks. The patient initially received benefit when the 
blocks were performed using ropivacaine. Subsequently the 
blocks were performed using liposomal bupivacaine, which 
has a longer duration of action measured in days, not hours.
In contrast, cryoneurolysis—also approved for the treat-
ment of acute and chronic pain—produces a reversible 
nerve block measured in weeks or months.2 In cases of 
chronic pain that has responded to local anesthetic-based 
nerve blocks, ultrasound-guided percutaneous cryoneurol-
ysis offers the benefits of a dramatically longer duration of 
analgesia, and, in the described case, possibly a decreased 
number of instrumentations. Because the risk of pneumo-
thorax has been reported as high as 1%–2% for each inter-
costal block performed,3 utilizing cryoneurolysis as an 
alternative to local anesthetic-based intercostal blocks may 
decrease the incidence of pneumothorax as well.
After 50 years of use, the published literature suggests a 
level of safety for cryoneurolysis exceeding local anesthetic-
based peripheral nerve blocks. There is no risk of local 
anesthetic toxicity, the risk of infection appears similar—if 
not lower—than for single-injection peripheral blocks, and 
no permanent neurologic injury has been reported.2 Two 
investigations reported a slight increase in the incidence 
of neuropathic pain for cryoneurolysis administered via 
the surgical incision following open thoracotomy, but the 
overwhelming majority of randomized, controlled trials of 
cryoneurolysis via the surgical incision have not reported 
any similar increased risk.4
Many questions remain regarding the use of ultrasound-
guided percutaneous cryoneurolysis for the treatment of 
acute and chronic pain. Nonetheless, due to its potential 
for providing long-term analgesia far surpassing local anes-
thetic-based peripheral nerve blocks—including liposomal 
bupivacaine—we propose that cryoanalgesia is at least 
worth considering in similar clinical situations. E
John J. Finneran IV, MD
Brian M. Ilfeld, MD, MS
Department of Anesthesiology
University of California San Diego
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